Figure 1

(A) Expression levels of Neuropilins 1 and 2, and of GIPC1, in various pancreatic carcinoma cell lines. (B) Knockdown of target gene mRNA mediated by optimal siRNAs, as determined in AsPC1 cells. (C) Western blots demonstrating the reduction of target gene protein levels in Panc89 cells.